NeuroMetrix Reports Progress on Quell Availability within the Veterans Health Administration
September 20 2016 - 7:00AM
Business Wire
NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today on
multiple efforts to increase the availability of Quell® Wearable
Pain Relief Technology™ to veterans who suffer from chronic pain
through the Veterans Health Administration.
The Company has successfully completed its registration process
in the U.S. federal government's System for Award Management (SAM),
a requirement for selling products to any federal government entity
including the Veterans Health Administration.
NeuroMetrix is also partnering with Marathon Medical
Corporation, a Service Disabled Veterans Owned Small Business
(SDVOSB) and medical supply distribution company, to provide Quell
to veterans through the Veterans Health Administration.
“While our core strategy is to offer Quell directly to
consumers, we are also committed to identifying distribution
channels that expand the number of people who have access to the
technology,” said Shai Gozani, M.D., Ph.D., President and CEO
of Neurometrix. “Since participating in a VA Health Summit in May
2016, we’ve been aware of the VA’s commitment to identifying
alternative approaches to pain management. We are hopeful that
relationships with Marathon Medical as well as individual VA
facilities will increase opportunities for veterans to try Quell
for pain relief.”
“We are always looking to add innovative products to our
offering,” said John St. Leger, President and CEO of Marathon
Medical Corporation. “We will utilize our expertise in delivering
medical supplies into the VA to expand access to Quell for
veterans.”
Quell can provide widespread relief from chronic pain for
veterans like Gerard DeWind, who is excited to be among the first
veterans to access Quell through his local VA hospital. “I have
chronic pain including arthritis in my right ankle. I was attracted
to Quell for its potential to help me sleep better and give me a
better quality of life.”
About Marathon Medical Corporation
Marathon Medical is a medical supply distribution company
founded in 2002. The company’s mission is to provide excellence and
professional personal service in the healthcare supply chain.
Marathon Medical’s corporate office and one warehouse are located
near Denver, CO with an additional location in Tampa, FL. Visit
Marathon Medical for more information.
About Quell
Quell is designed for millions of people suffering from chronic
pain. The advanced wearable device is lightweight and can be worn
during the day while active, and at night while sleeping. It has
been cleared by the FDA for treatment of chronic pain without a
prescription. In a recent study, 81% of Quell users reported an
improvement in their chronic pain. Quell users can start, stop, and
adjust therapy discreetly via the optional Quell Relief app. Quell
also offers advanced sleep tracking that provides feedback on eight
dimensions of sleep including sleep duration, quality, body
position, time out of bed, and repetitive leg movements throughout
the night. Quell was the winner of the 2016 SXSW (South by
Southwest) Innovation Award for Best Wearable Technology. For more
information, visit QuellRelief.com.
About NeuroMetrix
NeuroMetrix is a commercial stage, innovation driven
healthcare company combining bioelectrical and digital medicine to
address chronic health conditions including chronic pain, sleep
disorders, and diabetes. The company’s lead product is Quell, an
over-the-counter wearable therapeutic device for chronic pain.
Quell is integrated into a digital health platform that helps
patients optimize their therapy and decrease the impact of chronic
pain on their quality of life. The company also markets DPNCheck®,
a rapid point-of-care test for diabetic neuropathy, which is the
most common long-term complication of Type 2 diabetes. The company
maintains an active research effort and has several pipeline
programs, including a therapeutic device for restless leg syndrome.
The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health
Sciences and Technology in 1996. For more information, please
visit www.NeuroMetrix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160920005302/en/
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Mar 2024 to Apr 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Apr 2023 to Apr 2024